Introduction: Breath-hold diving-induced hemoptysis (BH-DIH) has been reported in about 25% breath-hold divers (BHD) and is characterized by dyspnea, coughing, hemoptysis and chest pain. We investigated whether eNOS G894T, eNOS T786C and ACE insertion/deletion I/D genetic variants, are possible BH-DIH risk factors.
Methods: 108 experienced healthy instructor BHDs with the same minimum requirements (102 male, six female; mean age 43.90 ± 7.49) were studied. We looked for different eNOS G894T, eNOS T786C and ACE insertion/ deletion genetic variants between BH-DIH-positive and BH-DIH-negative subjects to identify the variants most frequently associated with BH-DIH.
Results: At least one BH-DIH episode was reported by 22.2% of subjects, while 77.7% never reported BH-DIH. The majority of BH-DIH-positive subjects showed eNOS G894T (p = 0.001) and eNOS-T786C (p = 0.001) genotype "TT" (high-risk profile). Prevalence of BH-DIH was higher in subjects with eNOS G894T TT genotype (50%) than in subjects with GT (9.5%, p < 0.001) and GG (24%, (p = 0.0002) genotype (low-risk profile). Similar results were observed for eNOS T786C: BH-DIH prevalence was higher in the TT genotype (41.2%) group than in the CT (15.4%, p < 0.001) and CC genotype (9.1%, p < 0.001) groups. BH-DIH prevalence was significantly higher in subjects showing ACE ID genotype (34.5%) than II (0%, p < 0.001) and DD (10.5%, p = 0.0002). Of the ACE "II" genotype group, 100% never developed BH-DIH.
Discussion: eNOS-G894T, eNOS-T786C and ACE influence NO availability and regulation of peripheral vascular tone and blood flow. Different genetic variants of eNOS-G894T, eNOS-T786C and ACE appear significantly related to the probability to develop BH-DIH (p < 0.001).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Investigation of the relationships between eNOS T786C, G894T, intron 4 VNTR (4a/b) gene variations and prostate cancer development and progression.
Nitric Oxide
November 2024
Department of Urology, Faculty of Medicine, Trakya University, Edirne, Turkey, 22030. Electronic address:
Article Synopsis
- The study explored the link between specific gene variations (eNOS T786C, G894T, and intron 4 VNTR) and the occurrence and progression of prostate cancer among 88 patients and 91 healthy individuals.
- Results showed that certain genotypes, like CC in the T786C and TT in the G894T variations, were significantly more common in prostate cancer patients, indicating a potential genetic risk factor.
- The research also identified specific haplotypes associated with prostate cancer and healthy controls, suggesting that these gene variations might play a role in prostate cancer development.
Erectile dysfunction in cardiovascular patients: A prospective study of the eNOS gene T-786C, G894T, and INTRON variable number of the tandem repeat functional interaction.
Andrology
July 2024
Clinical Pharmacology Department, Pharmacogenetic Unit, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
Background: Cardiovascular disease induces erectile dysfunction modulated by endothelial nitric oxide synthase enzyme and an impaired ejection fraction that restricts penis vascular congestion. However, the mechanisms regulating endothelial dysfunction are not understood.
Objectives: Exploring the functional impact of endothelial nitric oxide synthase genetic polymorphisms on erectile dysfunction and drug therapy optimization in high-risk cardiovascular disease patients.
Endothelial Nitric Oxide Synthase T-786C and G-894T Gene Polymorphisms: A Risk Assessment of Coronary Heart Disease.
J Assoc Physicians India
September 2023
Professor and Head, Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India.
Article Synopsis
- - The study investigates how variations in the endothelial nitric oxide synthase (eNOS) gene may increase the likelihood of coronary heart disease (CHD) among young South Indians, focusing on specific genetic polymorphisms G-894T and T-786C.
- - Conducted from January to May 2022 with 91 CHD patients and 91 controls, the research involved blood sample analysis for nitric oxide levels and genetic testing using PCR and RFLP methods.
- - Results indicated significantly lower nitric oxide levels in CHD patients compared to controls, suggesting that the T-786C and G-894T gene polymorphisms are linked with an increased risk of CHD.
Genetic Polymorphisms of Endothelial Nitric Oxide Synthase Associated with Hypertension and Blood Homocysteine Levels.
Int J Gen Med
April 2024
Nutrition Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Article Synopsis
- Endothelial dysfunction is a major factor in hypertension, linked to eNOS impairment and high homocysteine levels, with specific genetic variations in eNOS associated with hypertension risk in Asian populations.
- The study involved 370 Thai men aged 40-60, analyzing genetic variants and blood parameters, finding that individuals with higher homocysteine levels had significantly elevated blood pressure.
- The research indicated that certain genetic variants (rs1799983 and rs2070744) also increase hypertension risk when combined with high homocysteine, suggesting these variants could inform hypertension management strategies.
Determination of the Roles of Endothelial Nitric Oxide Synthase 4VNTR (4a/b), G894T, T786C Gene Variations in the Bladder Cancer Development.
Indian J Clin Biochem
January 2024
Department of Urology, Faculty of Medicine, Trakya University, 22030 Edirne, Turkey.
The aim of this study is to determine the roles of eNOS gene variations in BCA development. Our study included 91 patients diagnosed with BCA and 91 healthy controls. eNOS 4VNTR (4a/b), T786C and G894T gene variations genotype distributions were determined by PCR and RFLP methods.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!